More than 50% of human pregnancies may be lost 1 , although in only 15% in this perceived as miscarriage 2 , with lower abdominal cramp and uterine bleeding being the presenting symptoms of threatened/inevitable abortion. An increasing proportion 0f these unsuccessful pregnancies is now diagnosed on routine ultrasound scanning and designated as mid trimester abortion. This terminology has been questioned recently3 but the term is still widely used and accepted by practicing clinicians. The word "mid trimester missed abortion " does not refer to the failure of the gynaecologist to diagnose the condition3, but to the missing uterine force which have failed to expel non viable product of conception.
Results:
A total 50 cases of missed abortion (12-28weeks) 
dose).24% cases needed oxytocin drip as an adjunct and 18% needed surgical evacuation when 4 doses of misoprostol (tab cytomis)and oxytocin fail to expel the product of conception. Mean (±SD) time required for expulsion of product of conception was 11.44 ± 4.43 hours in 29 (58%) women who were given tab misoprostol only. The results showed that 5(out of 25) has a complete expulsion after first dose , 13 after second 4 after 3 rd and Mean induction expulsion time was 6.1 hours The most common complication was temperature 6%, vomiting4%, and diarrhoea2%.

Conclusion: Vaginal application of misoprostol can be used to women with missed abortion for complete expulsion of the product of conception and may reduce the need for surgical intervention.
Currently a more interventional route is usually undertaken, with the uterus being evacuated soon after diagnosis. In the first trimester this is usually done by suction curettage, where as in the second trimester the uterus is generally quiescent and non responsive and at this stage termination by suction curettage is more traumatic than that in early pregnancy and complications are more common and may be more severe. In mid 1950s synthetic oxytocin was available and increasing doses were used to terminate mid trimester abortion. But in early 1980s, the local administration of prostaglandins were studied and the results were very promising. In clinically recognized pregnancies, spontaneous abortion occurs in 15% of cases. The rate is much higher for preclinical pregnancies. Diagnosis is much more frequent because of early use of ultrasonography. 6 If misoprostol proves safe and effective, a large number of patient will be benefited and will escape from surgical intervention and complication. 5 The present study was done to find out the efficacy of vaginal misoprostol for safe termination of mid trimester missed abortion.
Materials and Methods:
This was a prospective cross sectional study done in Obstetric and Gynaecology department of Dhaka Medical College Hospital (DMCH) over a period of nine months from August 2009 to April 2010.During this period all admitted cases of missed abortion within 12 to 28 weeks of gestational age, 50 cases were selected for the present study.
Only clinically diagnosed and ultrasonographically confirmed cases of mid trimester missed abortion were included for this study.
Patients with known hypersensitivity to prostaglandins and women having previous history of caesarian section were excluded from this study.
After taking detailed history and performing examination, an USG was done which is an integral part of diagnosis for missed abortion. After taking written informed consent Tab. Misoprostol (Marketed as Cytomis) 1tab = 200 microgram was introduced per vagina and applied in the posterior fornix. The doses were repeated every four hours for a total of 4 doses or until expulsion of the gestational sac, which one come earlier. Follow up was given at four hour interval or whenever the patient complaints of any problem. If the patient did not respond, then decision for other methods-like oxytocin induction or Foleys catheter or surgical evacuation was taken. An USG was done after 24 hours of expulsion to confirm complete abortion. Collected data were analyzed in SPSS.
Results:
Study population showed the age range was 17-40 years where the mean age was 23.6±6.06 (Table-I ). It also showed the parity range covered primi upto 4 th gravida with mean (±SD) was 1.22±1.28 (range 0-4) ( Table-I) . Most of the patients (56%) belonged to average socio economic status. Study population showed mean (±SD) gestation age of the women was 20.06±4.81 weeks (range 13-28 weeks). Seventeen (34%) cases belong to 13-16 weeks, 7 (14%) belong to 17-20 weeks, 13 (26%) belong to 21-24 weeks, 13 (26%) belong to 25-28 weeks gestation age. In this study, 29(58%) women required only tab misoprostol for expulsion of gestational sac and 12 (24%) women required oxytocin drip additionally. However the rest 9 (18%) women required (D&C) when Tab misoprostol and oxytocin drip failed to expel the gestational sac completely. Table- II. Mean (±SD) time required for expulsion of product of conception was 11.44±4.43 hours in 29 women who were given Tab misoprostol only, 20.13±1.25 hours in 12 women who were given Tab misoprostol followed by oxytocin drip, and 21.29±0.99 hours in 9 women who required D&C when Tab misoprostol and oxytocin drip failed to expel the product of conception completely ( Table -III) . Vaginal misoprostol treatment appeared to be well tolerated. Out of 10 patients with minor complaints, only 1 patient showed significant gastrointestinal side -effect, e.g. diarrhoea. None of the patients developed any major complications like-excessive haemorrhage, perforation, rupture, coagulopathy etc (Table -IV) . Table-V shows that complete expulsion of product of conception was achieved by only misoprostol in 29 (58%) cases, by misoprostol plus oxytocin in 9 (18%) cases and by misoprostol plus oxytocin plus D&C in 9 (18%) cases. In 3 (6%) cases, misoprostol + oxytocin resulted in incomplete expulsion and then they were completed by D&C. Only Tab cytomis was required in maximum number of women in gestational age group 21-24 weeks (76.9%) and 25-28 weeks (69.23%), Tab cytomis and oxytocin drip were used in maximum 2(15.38%) women in gestational age group 21-24 weeks, and surgery was required in maximum number of women in gestational age group 13 -16 weeks (29.42%). 
Discussion:
Missed abortion is a common complication of early pregnancy, occurring in upto 15 percent of all clinically recognised pregnancies. 7 The majority of cases are currently treated by dilatation and curettage (D&C). The rationale that all spontaneous abortions should be treated with D&C to prevent infection and haemorrhage has been questioned. 8 Treatment of incomplete abortion with misoprostol has also been reported with varying degree of success. 9, 10 With the rising use of early ultrasound, an increasing number of miscarriages present as missed abortions before the onset of cramping and bleeding. A small case series reported that seven of eight women with missed abortion had a complete abortion after treatment with vaginal misoprostol compared with three of 12 treated by oral route. 11 This study was carried out to find out the efficacy of this new drug (misoprostol) in the expulsion of product of conception with special attention to number of doses required and induction-expulsion interval and need for additional oxytocin/surgical evacuation.
In a study coducted by Zalanyi using vaginal misoprostol for missed abortion,on women having gravidity 2.4±1.42 and parity 1.0±0.84. The study included only cases of amenorrhoea of upto 13 weeks, where as, our study included mid-trimester cases. 12 The efficacy of vaginal misoprostol was also studied for medical management of missed abortion by Wood 13 , where gestational age of the patients ranged from 7-17 weeks (median 12 weeks)and 56 percent of the patients were nulliparous. 13 In both the above studies, vaginal misoprostol was found to be quite effective in expulsion of production of conception in missed abortion cases, reducing the need for surgical evacuation.
In the present study, 58 percent (29 out of 50) experienced complete expulsion (20% after 1 st dose, 24% after 2 nd dose, 24% after 3 rd dose, 31% after 4 th dose). Twenty four percent cases needed oxytocin drip as an adjunct and 18percent needed surgical evacuation when four doses of misoprostol (tab cytomis) and oxytocin failed to expel the product of conception.
Mean (±SD) time required for expulsion of product of conception was 11.44±4.43 hours in 29 (58%) women who were given Tab misoprostol only. In others, the time was much higher. The side effects experienced by the patients were negligible, only two patients (4%) had gastrointestinal cramps and diarrhoea, 3(6%) patents experienced febrile reaction and 4(8%) patients complained of nausea. Only 7 (14%) cases who needed surgical evacuation.
In a study conducted by Zalanyi (Hungary), misoprostol 200µg was used vaginally for expulsion of product of conception in missed abortion. 14 The results showed that 5 (out of 25) has a complete expulsion after 1 st dose, 13 after second, 4 after third and the mean induction-expulsion time was 6.1hours (calculated only for successful cases). Three patients did not abort even after four doses, who required surgical evacuation of the uterus. There was no febrile complications. 14 In a study carried out by Wood, 80 percent subjects aborted completely after two vaginal doses of 800 µg of misoprostol tablet. It may be noted that dose used was quite high in comparison to the present study. In that study, there was also an additional benefit of having soft dilated cervix found during surgical treatment.
In a study by Refacy et al. it was found that vaginal misoprostol administration was more effective than the oral route. The local effect of misoprostol on the the cervix was considered to be one of the reason. 15 In a study carried out in Bangladesh by Barua , using two tablets of misoprostol vaginaly, it was found that 60. 71 percent patients had complete expulsion with vaginal misoprostol, and among these, 42.85 percent patients responded with 1 st dose of 400µg of misoprostol, mean (±SD) induction-expulsion time being 8.30±2.53 hours. Only one patient (out of 56) experienced shivering as a complication and (out of 56) developed severe bleeding. 16 This study showed that complete expulsion was more in patients with higher gestational age (21-24weeks).
Patients who were of 13-16 weeks gestational age needed more surgical evacuation.
In this study, a number of patients needed surgical evacuation, but one of the important observations is that in this case cervix was very soft and somewhat dilated during evacuation which reduced requirement of dilatation and less use of analgesics.
In this study no life threatening complications were observed like massive haemorrhage, perforation, spontaneous rupture, coagulopathy etc.
Conclusion:
Obstreticians/gynaecologists have recently been challenged to rethink their approach to miscarriage. Furthermore, the high success rates (more than 90%) in the medical therapeutic abortion also suggest that non-surgical treatment should be considered.
From this small study, it is anticipated that medical management of missed abortion with vaginal misoprostol will prove to be a good alternative to surgical evacuation.
